Healthcare provider profile · identity verified

Susan M Fiore, MD

Family Practice · ANDES, NY · NPI 1003869884

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	166	43
Atorvastatin Calcium	Atorvastatin Calcium	128	35
Lisinopril	Lisinopril	122	38
Amlodipine Besylate	Amlodipine Besylate	109	35
Pantoprazole Sodium	Pantoprazole Sodium	101	30
Metoprolol Succinate	Metoprolol Succinate	86	27
Omeprazole	Omeprazole	86	31
Losartan Potassium	Losartan Potassium	84	27
Rosuvastatin Calcium	Rosuvastatin Calcium	71	23
Metformin Hcl	Metformin Hcl	70	20
Simvastatin	Simvastatin	69	20
Allopurinol	Allopurinol	68	16
Hydrochlorothiazide	Hydrochlorothiazide	61	18
Tamsulosin Hcl	Tamsulosin Hcl	61	18
Alprazolam	Alprazolam	60	14
Famotidine	Famotidine	56	21
Fluticasone Propionate	Fluticasone Propionate	55	27
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	55	11
Pravastatin Sodium	Pravastatin Sodium	53	14
Finasteride	Finasteride	43	11
Sertraline Hcl	Sertraline Hcl	43	15
Albuterol Sulfate Hfa	Albuterol Sulfate	42	21
Furosemide	Furosemide	42	14
Doxycycline Hyclate	Doxycycline Hyclate	41	38
Atenolol	Atenolol	40	13
Gabapentin	Gabapentin	40	14
Oxycodone Hcl	Oxycodone Hcl	39	11
Carvedilol	Carvedilol	37	14
Lorazepam	Lorazepam	37	13
Glipizide	Glipizide	35	11
Metoprolol Tartrate	Metoprolol Tartrate	35	11
Azithromycin	Azithromycin	34	23
Eliquis	Apixaban	33	11
Metformin Hcl Er	Metformin Hcl	31	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	30	suppressed
Tramadol Hcl	Tramadol Hcl	28	11
Cephalexin	Cephalexin	27	23
Ibandronate Sodium	Ibandronate Sodium	27	suppressed
Trazodone Hcl	Trazodone Hcl	27	11
Prednisone	Prednisone	26	17
Zolpidem Tartrate	Zolpidem Tartrate	26	suppressed
Potassium Chloride	Potassium Chloride	25	suppressed
Synthroid	Levothyroxine Sodium	25	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	16
Donepezil Hcl	Donepezil Hcl	23	suppressed
Ezetimibe	Ezetimibe	23	suppressed
Meloxicam	Meloxicam	23	suppressed
Warfarin Sodium	Warfarin Sodium	23	suppressed
Clopidogrel	Clopidogrel Bisulfate	22	suppressed
Estradiol	Estradiol	22	suppressed
Duloxetine Hcl	Duloxetine Hcl	21	suppressed
Naproxen	Naproxen	20	suppressed
Ramipril	Ramipril	18	suppressed
Alendronate Sodium	Alendronate Sodium	17	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	17	suppressed
Citalopram Hbr	Citalopram Hydrobromide	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Spironolactone	Spironolactone	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	14
Armour Thyroid	Thyroid,pork	15	suppressed
Jardiance	Empagliflozin	15	suppressed
Clotrimazole	Clotrimazole	14	11
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Pregabalin	Pregabalin	14	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	14	suppressed
Valsartan	Valsartan	14	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Torsemide	Torsemide	13	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Sympazan	Clobazam	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Diazepam	Diazepam	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Phenobarbital	Phenobarbital	11	suppressed
Risperidone	Risperidone	11	suppressed
Sotalol	Sotalol Hcl	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error